Dr. Habeebullah Life Sciences
Samsrita Labs Limited, formerly known as Dr Habeebullah Life Sciences Limited, is an integrated global bio-pharmaceutical company dedicated to advancing research and development in stem cell sciences, RNAi therapeutics, regenerative medicine, and biomarker discovery. The company focuses on innovative therapies, stem cell research, and diagnostic solutions to improve human health.
Industries
Nr. of Employees
small (1-50)
Dr. Habeebullah Life Sciences
Envato Level 13, 2 Elizabeth Victoria 3000 Australia
Products
Molecular oncology biomarker assay panels (under development)
Panels of molecular biomarker assays under development targeting oncology indications including breast, gastric and colon cancer for screening, diagnosis and prognostic use.
Novel therapeutic compound pipeline
Pipeline of novel small-molecule compounds discovered via synthetic organic chemistry research targeting hepatic, neurodegenerative, cardiovascular and oncology indications.
Stem cell therapy product pipeline
Development portfolio of stem cell–based therapeutic programs spanning gastroenterology, neurology, orthopedics, oncology, cardiology, diabetes and cosmetic applications.
Molecular oncology biomarker assay panels (under development)
Panels of molecular biomarker assays under development targeting oncology indications including breast, gastric and colon cancer for screening, diagnosis and prognostic use.
Novel therapeutic compound pipeline
Pipeline of novel small-molecule compounds discovered via synthetic organic chemistry research targeting hepatic, neurodegenerative, cardiovascular and oncology indications.
Stem cell therapy product pipeline
Development portfolio of stem cell–based therapeutic programs spanning gastroenterology, neurology, orthopedics, oncology, cardiology, diabetes and cosmetic applications.
Services
Clinic-based delivery of stem cell therapies across gastroenterology, neurology, orthopedics, oncology, cardiology, diabetes and cosmetic indications.
Production, processing and storage services for therapeutic cells and cord blood units for clinical use.
End-to-end biomarker discovery, assay design and development for diagnostic and prognostic applications, including circulating biomarker analysis.
Analytical validation of biomarker assays and development support for companion diagnostics including regulatory submission assistance.
Identification and preclinical development of microRNA-based therapeutic candidates, including design of mimics and antagonists and oligonucleotide chemistry optimization.
Discovery and synthesis of novel small-molecule compounds supported by synthetic organic chemistry facilities.
Clinic-based delivery of stem cell therapies across gastroenterology, neurology, orthopedics, oncology, cardiology, diabetes and cosmetic indications.
Production, processing and storage services for therapeutic cells and cord blood units for clinical use.
End-to-end biomarker discovery, assay design and development for diagnostic and prognostic applications, including circulating biomarker analysis.
Analytical validation of biomarker assays and development support for companion diagnostics including regulatory submission assistance.
Identification and preclinical development of microRNA-based therapeutic candidates, including design of mimics and antagonists and oligonucleotide chemistry optimization.
Discovery and synthesis of novel small-molecule compounds supported by synthetic organic chemistry facilities.
Expertise Areas
- Stem cell R&D and regenerative medicine
- Cell therapy production and cord blood banking
- Biomarker discovery and molecular diagnostics
- microRNA / RNAi therapeutics
Key Technologies
- microRNA / RNA interference (RNAi)
- Oligonucleotide therapeutics and chemistry
- Real-time PCR
- High-performance liquid chromatography (HPLC)